These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 172080)

  • 21. Experimental nephrotic syndrome: removal and tissue distribution of chylomicrons and very-low-density lipoproteins of normal and nephrotic origin.
    Levy E; Ziv E; Bar-On H; Shafrir E
    Biochim Biophys Acta; 1990 Apr; 1043(3):259-66. PubMed ID: 2322571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Functional classification of lipoprotein particles of triglyceride transport (hypothesis)].
    Titov VN
    Klin Lab Diagn; 1996; (4):46-51. PubMed ID: 8963561
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of the liver in lipoprotein catabolism.
    Havel RJ
    Methods Enzymol; 1986; 129():591-612. PubMed ID: 3523159
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapid movement of lipoprotein lipase among substrate globules.
    Nutr Rev; 1985 Jan; 43(1):29-30. PubMed ID: 3885082
    [No Abstract]   [Full Text] [Related]  

  • 25. Vitamin D3 uptake by the isolated perfused rat liver from lipoprotein fractions is separate from cholesterol and triglyceride uptake.
    Ziv E; Bar-On H; Silver J
    Eur J Clin Invest; 1985 Apr; 15(2):95-9. PubMed ID: 2986986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The physiology of lipoprotein metabolism].
    Assmann G
    Infusionsther Klin Ernahr; 1983 Aug; 10(4):162-70. PubMed ID: 6618657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein C-II deficiency. The role of apolipoprotein C-II in the hydrolysis of triacylglycerol-rich lipoproteins.
    Haberbosch W; Poli A; Baggio G; Fellin R; Gnasso A; Augustin J
    Biochim Biophys Acta; 1984 Mar; 793(1):49-60. PubMed ID: 6704413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-migrating very-low-density lipoprotein, chylomicron remnants and their receptors.
    Liao W
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):359. PubMed ID: 7646468
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-migrating very-low-density lipoproteins and chylomicron remnants bind to rat liver hepatocytes at a low-density-lipoprotein-receptor-independent site (the remnant receptor).
    Van Berkel JC; Voorschuur A; Kuiper J
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):359-60. PubMed ID: 7646469
    [No Abstract]   [Full Text] [Related]  

  • 30. [Plasma transport and fate of chylomicrons and VLDL in normal humans].
    Fruchart JC; Sezille G
    Med Chir Dig; 1978; 7(2):121-7. PubMed ID: 207937
    [No Abstract]   [Full Text] [Related]  

  • 31. Peripheral vascular disease in cigarette smokers and impaired hepatic metabolism of lipoprotein remnants.
    Topping DL; Dwyer T; Weller RA
    Lancet; 1977 Dec 24-31; 2(8052-8053):1327-8. PubMed ID: 74734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma lipoproteins: recent developments.
    Gotto AM; Jackson RL
    Adv Exp Med Biol; 1977; 82():15-33. PubMed ID: 200086
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma lipoproteins and apolipoproteins.
    Fredrickson DS
    Harvey Lect; 1974; 68():185-237. PubMed ID: 4375673
    [No Abstract]   [Full Text] [Related]  

  • 34. Receptor-dependent targeting of lipoproteins to specific cell types of the liver.
    Van Berkel TJ; Kruijt JK; De Smidt PC; Bijsterbosch MK
    Targeted Diagn Ther; 1991; 5():225-49. PubMed ID: 1724611
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolism of apolipoproteins and the metabolic heterogeneity of apo B in the rat.
    Marsh JB
    Adv Exp Med Biol; 1985; 183():99-112. PubMed ID: 4036707
    [No Abstract]   [Full Text] [Related]  

  • 36. Fatty acid and triacylglycerol utilisation by perfused rat spleen: differential metabolic fate and the effect of endotoxin.
    Hauton D; Evans RD
    Cell Physiol Biochem; 2002; 12(2-3):143-52. PubMed ID: 12077560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding, uptake, and metabolism of chylomicron remnants by hepatocytes from control and chronic ethanol-fed rats.
    Lakshmanan MR; Ezekiel M; Campbell BS; Muesing RA
    Alcohol Clin Exp Res; 1986 Aug; 10(4):412-8. PubMed ID: 3530018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The origin and fate of chylomicrons and VLDL.
    Havel RJ
    Adv Exp Med Biol; 1977; 82():406-12. PubMed ID: 200100
    [No Abstract]   [Full Text] [Related]  

  • 39. Modern management of hyperlipidemia.
    Grundy SM
    Compr Ther; 1984 Sep; 10(9):46-53. PubMed ID: 6091992
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipoprotein metabolism.
    Eisenberg S; Levy RI
    Adv Lipid Res; 1975; 13():1-89. PubMed ID: 174409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.